AU690794B2 - Anti-inflammatory eyedrops - Google Patents

Anti-inflammatory eyedrops

Info

Publication number
AU690794B2
AU690794B2 AU43156/96A AU4315696A AU690794B2 AU 690794 B2 AU690794 B2 AU 690794B2 AU 43156/96 A AU43156/96 A AU 43156/96A AU 4315696 A AU4315696 A AU 4315696A AU 690794 B2 AU690794 B2 AU 690794B2
Authority
AU
Australia
Prior art keywords
eyedrops
inflammatory
diclofenac sodium
irritate
cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43156/96A
Other languages
English (en)
Other versions
AU4315696A (en
Inventor
Makoto Maeda
Hiroki Maruyama
Touru Oguma
Hiroe Suzuki
Masanobu Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Publication of AU4315696A publication Critical patent/AU4315696A/en
Application granted granted Critical
Publication of AU690794B2 publication Critical patent/AU690794B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU43156/96A 1995-01-20 1995-12-26 Anti-inflammatory eyedrops Ceased AU690794B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-24485 1995-01-20
JP2448595 1995-01-20
PCT/JP1995/002680 WO1996022088A1 (fr) 1995-01-20 1995-12-26 Gouttes oculaires anti-inflammatoires

Publications (2)

Publication Number Publication Date
AU4315696A AU4315696A (en) 1996-08-07
AU690794B2 true AU690794B2 (en) 1998-04-30

Family

ID=26361998

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43156/96A Ceased AU690794B2 (en) 1995-01-20 1995-12-26 Anti-inflammatory eyedrops

Country Status (11)

Country Link
US (1) US5929115A (fi)
EP (1) EP0807434B1 (fi)
JP (1) JP3672569B2 (fi)
AT (1) ATE215821T1 (fi)
AU (1) AU690794B2 (fi)
CA (1) CA2210749C (fi)
DE (1) DE69526369T2 (fi)
FI (1) FI973060A0 (fi)
NO (1) NO973343L (fi)
RU (1) RU2136252C1 (fi)
WO (1) WO1996022088A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4215277B2 (ja) * 1996-08-09 2009-01-28 アルコン ラボラトリーズ，インコーポレイテッド シクロデキストリンを含有する薬学的組成物用防腐剤系
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
US20040013729A1 (en) * 2002-07-18 2004-01-22 Buono Lawrence M. Single-drop multiple-agent composition for topical delivery to the eye
US20060036220A1 (en) * 2003-01-22 2006-02-16 Kohji Kawahara Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
JP4947977B2 (ja) * 2003-10-31 2012-06-06 わかもと製薬株式会社 可逆性熱ゲル化水性組成物
KR20170123724A (ko) * 2006-03-28 2017-11-08 자블린 파머슈티칼스 인코포레이티드 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형
CN101410012A (zh) * 2006-03-28 2009-04-15 杰佛林制药公司 低剂量的非甾体抗炎药和β-环糊精的制剂
EP2726060B1 (en) * 2011-06-29 2019-12-25 Allergan, Inc. Macrogol 15 hydroxystearate formulations
US9566301B2 (en) * 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
CN109715215A (zh) * 2016-05-06 2019-05-03 沙驰公司 眼用组合物
US11110073B2 (en) * 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
CN111225687A (zh) * 2017-09-01 2020-06-02 默里和普尔企业有限公司 用于治疗眼科疾患的方法和组合物
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
JP2024507329A (ja) * 2021-01-22 2024-02-19 チョンドゥー ルイムー バイオファーマスーティカルズ カンパニー リミテッド 点眼投与により黄斑浮腫、視神経炎および非感染性眼内炎を治療するための眼科用製剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58174310A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 抗炎症点眼剤
JPS58174309A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 消炎点眼剤
JPS5929616A (ja) * 1982-08-10 1984-02-16 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPS60136516A (ja) * 1983-12-26 1985-07-20 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
DE3612537C1 (de) * 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
DE3870111D1 (de) * 1987-09-11 1992-05-21 Syntex Inc Schutzmittel fuer augenzubereitungen.
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
TW200402B (fi) * 1990-08-13 1993-02-21 Senju Pharma Co
JPH0616547A (ja) * 1992-07-01 1994-01-25 Wakamoto Pharmaceut Co Ltd 消炎点眼剤
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
WO1994010976A1 (en) * 1992-11-16 1994-05-26 Ciba Vision Ag, Hettlingen Polyvinyl alcohol/borate ophthalmic drug delivery system
RU2049467C1 (ru) * 1993-04-16 1995-12-10 Научно-исследовательская фирма "Ультрасан" Антибактериальный, противовоспалительный препарат
RU2062079C1 (ru) * 1993-08-25 1996-06-20 Уфимский научно-исследовательский институт глазных болезней Глазные капли
US5576311A (en) * 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions

Also Published As

Publication number Publication date
ATE215821T1 (de) 2002-04-15
NO973343D0 (no) 1997-07-18
NO973343L (no) 1997-09-19
EP0807434B1 (en) 2002-04-10
FI973060A (fi) 1997-07-18
EP0807434A1 (en) 1997-11-19
US5929115A (en) 1999-07-27
WO1996022088A1 (fr) 1996-07-25
DE69526369D1 (de) 2002-05-16
EP0807434A4 (en) 1998-04-22
RU2136252C1 (ru) 1999-09-10
FI973060A0 (fi) 1997-07-18
JP3672569B2 (ja) 2005-07-20
AU4315696A (en) 1996-08-07
CA2210749C (en) 2001-04-10
DE69526369T2 (de) 2002-11-07
CA2210749A1 (en) 1996-07-25

Similar Documents

Publication Publication Date Title
AU690794B2 (en) Anti-inflammatory eyedrops
AU3421895A (en) Amino(thio)ether derivatives
AU633754B2 (en) Composition for eye drops
CA2167383A1 (en) Ophthalmic solution based on diclofenac and tobramycine and its applications
CA2194564A1 (en) Aqueous Risperidone Formulations
CA2185512A1 (en) Treatment of Tinnitus Using Neuroprotective Agents
AU5162796A (en) Novel peptide derivatives
CA2219818A1 (en) Novel compounds, the preparation and use thereof
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
AU6874296A (en) Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
AU3053495A (en) 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives
AU4329396A (en) Use of 3,4-diphenylchromans
CA2189424A1 (en) Non-steroidal anti-inflammatory ophthalmic suspensions
AU5317390A (en) Concentrated aqueous solution of glutaraldehyde and 1,2-benzisothiazolin-3-one
AU1031697A (en) Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
AU6707096A (en) Alpha-methoxymethylene or alpha-methoxyimino naphthylacetic acid derivatives and their use as fungicides
AU4581996A (en) Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl- pyridinyl and pyrimidinylpiperazines
WO1989012380A3 (en) Therapeutic uses of 2',5'-oligoadenylate derivatives
AU5707090A (en) Hair treatment composition
AU563822B2 (en) Pharmaceutical composition of piroxicam and 5'-guanylic acid or n-acetyl-l-methionine
AU7315596A (en) Pharmaceutical composition for topical application
AU5635496A (en) Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-he xulofluranosonic acid
AU7144894A (en) Acivicin, derivatives of acivicin, salts of acivicin and salts of derivatives of acivicin as herbicides
AU6418396A (en) Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired